REGENERON PHARMACEUTICALS INC
Federal contract awards won by REGENERON PHARMACEUTICALS INC (UEI N3F9MH7E6HD6), 2016–2021 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
5
awards
1
expiring in 12 months
3
agencies
Category award history
2 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: ADVANCED ACCELERATOR APPLICATIONS USA INC took Department of Veterans Affairs 325412 work from REGENERON PHARMACEUTICALS INC (Nov 23, 2022).
Agencies buying from REGENERON PHARMACEUTICALS INC
What REGENERON PHARMACEUTICALS INC has provided
Awards
EVKEEZA DRUG
Department of Veterans Affairs · $494,095 · Nov 24, 2021
PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.
Department of Defense · $5,565,000,000 · Jan 12, 2021
IGF::OT::IGF
Department of Health and Human Services · $973,560,407 · Sep 30, 2017
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Department of Health and Human Services · $278,844,172 · Sep 21, 2017
IGF::OT::IGF
Department of Health and Human Services · $8,601,629 · Aug 9, 2016